Richiedi una copia del documento: Treatment simplification to atazanavir/ritonavir plus lamivudine versus maintenance of atazanavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in virologically-suppressed HIV-1-infected patients : 48-weeks results from a randomized trial (ATLAS-M)

Captcha code
Annulla